PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

SLAS
Bio IT
PEGS Boston
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost

Advertisement

A&M Stabtest April 26
Scientific Lab Show
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
QMB Innovation Centre
Polypure hompage

Congenital Hyperinsulinism Treatment Gaps and a Potential Solution

Although rare diseases, by definition, affect fewer individuals than other diseases do, they tend to be particularly devastating: they are often debilitating or lethal. It is estimated that as many as 7000 rare diseases exist globally. While the number of individuals with a specific rare disease may be small, the total number of people with any rare disease is quite large. Dr. Roberts at Rezolute, Inc. discusses new avenues of treatment for congenital HI.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2020/07/Congenital-Hyperinsulinism-Treatment-Gaps.pdf”]

The Bridge 28.01
Newcells 3 June 2024, 15:12
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Aseptic Tech
PharmExcel